Caris Life Sciences (CAI) net assets (shareholders' equity)

Net assets · fiscal 2025
$577.31M

Caris Life Sciences (CAI) had net assets of $577.31M at the end of fiscal 2025 (December 31, 2025). In fiscal 2024 the figure was -$2.50B. Figures as of 19 Nov 2026, 11:31 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$577.31M
Highest on record
$577.31Mfiscal 2025
Lowest on record
-$2.50Bfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Caris Life Sciences net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $577.31M in fiscal 2025 and the lowest -$2.50B in fiscal 2024.

History · 4 fiscal years

Net assets by fiscal year

Caris Life Sciences net assets (shareholders' equity), year by year

Caris Life Sciences (CAI) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$577.31M—
2024-$2.50B—
2023-$2.14B—
2022-$1.70B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Caris Life Sciences and comparable companies
CompanyNet assetsFiscal year
Cytokinetics CYTK-$659.63M2025
ABIVAX ABVX€455.21M2025
Bausch + Lomb BLCO$6.45B2025
Amneal Pharmaceuticals AMRX-$70.79M2025
Caris Life Sciences CAI$577.31M2025
Immunovant IMVT$852.59M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CAI

Caris Life Sciences, figure by figure

Caris Life Sciences (CAI) overview: price, valuation and scorecardAll health care companies by market value

Caris Life Sciences net assets (shareholders' equity): questions and answers

What are Caris Life Sciences's net assets?

Caris Life Sciences (CAI) had net assets of $577.31M at the end of fiscal 2025 (December 31, 2025). In fiscal 2024 the figure was -$2.50B.

What are the highest and lowest net assets figures on record for Caris Life Sciences?

Across the 4 fiscal years on record (2022–2025), the highest was $577.31M in fiscal 2025 and the lowest -$2.50B in fiscal 2024.

How is Caris Life Sciences's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Caris Life Sciences it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Caris Life Sciences (CAI) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/CAI/net-assets

Underlying data: Yahoo Finance.